Skip to content

Based on "pre-asthma lesions" to explore the efficacy evaluation of The NO.1 XiaoQian Prescription in the prevention and treatment of children with

pediatrics of integrated Chinese and Western medicine

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005648
Enrollment
Unknown
Registered
2022-02-19
Start date
2022-04-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

wheeze

Interventions

The western medicine group:Montelukast
Chinese traditional medicine group:xiao Qian Formula 1

Sponsors

Xiyuan Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 5 Years

Inclusion criteria

Inclusion criteria: (1) Children aged 3-5 years; (2) Children with past symptoms of wheezing and mAPI positive; (3) The guardian can cooperate with the medical records, complete the scale and agree to participate in the study; (4) Those who had used glucocorticoids, leukotriene receptor antagonists and Traditional Chinese medicine should stop taking drugs for one month before participating in this study.

Exclusion criteria

Exclusion criteria: (1)Children with negative mAPI, or have been diagnosed with childhood asthma; (2) Patients who had taken glucocorticoid, leukotriene receptor antagonist and Traditional Chinese medicine in the last one month; (3) The guardian has poor communication ability and compliance and cannot cooperate to complete the test; (4) Children with congenital diseases or other diseases with serious complications; (5) Wheezing caused by other reasons

Design outcomes

Primary

MeasureTime frame
Number and frequency of wheezing attacks;Incidence of children asthma;

Secondary

MeasureTime frame
Unable to go out for normal hours due to illness;Pulmonary function test;The emergency number;Blood Biochemistry;Hospitalization days;The daily cost;TRACK table;The number of times you hold in at night;ECG;Routine blood;FeNO;Number of emergency drug use;Number of activity restrictions;

Countries

china

Contacts

Public ContactCHEN XUN
chenxun1212@qq.com18518720592

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026